VISINE

This brand name is authorized in Croatia, Ecuador, Estonia, Germany, Israel, Lithuania, New Zealand, Poland, Romania, Turkey.

Active ingredients

The drug VISINE contains one active pharmaceutical ingredient (API):

1	Tetryzoline UNII S9U025Y077 - TETRAHYDROZOLINE
	Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.
	Read more about Tetryzoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GA02	Tetryzoline	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	04081171, 05965469, 15298442
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	362621012, 6862-MEE-1221
EE	Ravimiamet	1016648, 1790085
HR	Agencija za lijekove i medicinske proizvode	HR-H-564603810
IL	מִשְׂרַד הַבְּרִיאוּת	1185
LT	Valstybinė vaistų kontrolės tarnyba	1008061, 1066847, 1085843, 1092181
NZ	Medicines and Medical Devices Safety Authority	532, 8922
PL	Rejestru Produktów Leczniczych	100070747, 100418469, 100425179
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64914001, W64914002, W67737001
TR	İlaç ve Tıbbi Cihaz Kurumu	8683873461424